Luye Pharma Group Ltd. - Net Worth and Insider Trading

Luye Pharma Group Ltd. Net Worth

The estimated net worth of Luye Pharma Group Ltd. is at least $3.3 Billion dollars as of 2024-06-22. Luye Pharma Group Ltd. is the of Shandong Boan Biotechnology Co Ltd and owns about 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) stock worth over $3.3 Billion. Details can be seen in Luye Pharma Group Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luye Pharma Group Ltd. has not made any transactions after 2024-04-12 and currently still holds the listed stock(s).

Transaction Summary of Luye Pharma Group Ltd.

Luye Pharma Group Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luye Pharma Group Ltd. owns 1 companies in total, including Shandong Boan Biotechnology Co Ltd (HKSE:06955) .

Click here to see the complete history of Luye Pharma Group Ltd.’s form 4 insider trades.

Insider Ownership Summary of Luye Pharma Group Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06955	Shandong Boan Biotechnology Co Ltd	2024-04-12

Luye Pharma Group Ltd. Latest Holdings Summary

Luye Pharma Group Ltd. currently owns a total of 1 stock. Luye Pharma Group Ltd. owns 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) as of April 12, 2024, with a value of $3.3 Billion.

Latest Holdings of Luye Pharma Group Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06955	Shandong Boan Biotechnology Co Ltd	2024-04-12	360,596,456	9.19	3,313,881,431

Holding Weightings of Luye Pharma Group Ltd.

Luye Pharma Group Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Luye Pharma Group Ltd. has made a total of 4 transactions in Shandong Boan Biotechnology Co Ltd (HKSE:06955) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shandong Boan Biotechnology Co Ltd is the sale of 0 shares on April 12, 2024, which brought Luye Pharma Group Ltd. around $0.

Insider Trading History of Luye Pharma Group Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luye Pharma Group Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Luye Pharma Group Ltd. Ownership Network

Ownership Network List of Luye Pharma Group Ltd.

No Data

Ownership Network Relation of Luye Pharma Group Ltd.

Luye Pharma Group Ltd. Owned Company Details

What does Shandong Boan Biotechnology Co Ltd do?

Who are the key executives at Shandong Boan Biotechnology Co Ltd?

Luye Pharma Group Ltd. is the of Shandong Boan Biotechnology Co Ltd. Other key executives at Shandong Boan Biotechnology Co Ltd include AsiaPharm Investments Ltd. , Ginkgo (PTC) Limited , and Liu Dianbo .

Shandong Boan Biotechnology Co Ltd (HKSE:06955) Insider Trades Summary

Over the past 18 months, Luye Pharma Group Ltd. made 4 insider transaction in Shandong Boan Biotechnology Co Ltd (HKSE:06955) with a net sale of 0. Other recent insider transactions involving Shandong Boan Biotechnology Co Ltd (HKSE:06955) include a net sale of 0 shares made by yan tai lv ye yi yao kong gu ji tuan you xian gong si , a net sale of 0 shares made by Luye Pharma Holdings Ltd. , and a net sale of 0 shares made by LuYe Pharmaceutical International Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shandong Boan Biotechnology Co Ltd (HKSE:06955)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shandong Boan Biotechnology Co Ltd Insider Transactions

No Available Data

Luye Pharma Group Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Luye Pharma Group Ltd.. Currently GuruFocus does not have mailing address information for Luye Pharma Group Ltd..

Discussions on Luye Pharma Group Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.